FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280496857> ?p ?o ?g. }

• W4280496857 endingPage "150" @default.
• W4280496857 startingPage "143" @default.
• W4280496857 abstract "Chronic neuroinflammation and microglial dysfunction are key features of many neurological diseases, including Alzheimer's Disease and multiple sclerosis. While there is unfortunately a dearth of highly selective molecular imaging biomarkers/probes for studying microglia in vivo, P2Y12R has emerged as an attractive candidate PET biomarker being explored for this purpose. Importantly, P2Y12R is selectively expressed on microglia in the CNS and undergoes dynamic changes in expression according to inflammatory context (e.g., toxic versus beneficial/healing states), thus having the potential to reveal functional information about microglia in living subjects. Herein, we identified a high affinity, small molecule P2Y12R antagonist (AZD1283) to radiolabel and assess as a candidate radiotracer through in vitro assays and in vivo positron emission tomography (PET) imaging of both wild-type and total knockout mice and a non-human primate.First, we evaluated the metabolic stability and passive permeability of non-radioactive AZD1283 in vitro. Next, we radiolabeled [11C]AZD1283 with radioactive precursor [11C]NH4CN and determined stability in formulation and human plasma. Finally, we investigated the in vivo stability and kinetics of [11C]AZD1283 via dynamic PET imaging of naïve wild-type mice, P2Y12R knockout mouse, and a rhesus macaque.We determined the half-life of AZD1283 in mouse and human liver microsomes to be 37 and > 160 min, respectively, and predicted passive CNS uptake with a small amount of active efflux, using a Caco-2 assay. Our radiolabeling efforts afforded [11C]AZD1283 in an activity of 12.69 ± 10.64 mCi with high chemical and radiochemical purity (>99%) and molar activity of 1142.84 ± 504.73 mCi/μmol (average of n = 3). Of note, we found [11C]AZD1283 to be highly stable in vitro, with >99% intact tracer present after 90 min of incubation in formulation and 60 min of incubation in human serum. PET imaging revealed negligible brain signal in healthy wild-type mice (n = 3) and a P2Y12 knockout mouse (0.55 ± 0.37%ID/g at 5 min post injection). Strikingly, high signal was detected in the liver of all mice within the first 20 min of administration (peak uptake = 58.28 ± 18.75%ID/g at 5 min post injection) and persisted for the remaining duration of the scan. Ex vivo gamma counting of mouse tissues at 60 min post-injection mirrored in vivo data with a mean %ID/g of 0.9% ± 0.40, 0.02% ± 0.01, and 106 ± 29.70% in the blood, brain, and liver, respectively (n = 4). High performance liquid chromatography (HPLC) analysis of murine blood and liver metabolite samples revealed a single radioactive peak (relative area under peak: 100%), representing intact tracer. Finally, PET imaging of a rhesus macaque also revealed negligible CNS uptake/binding in monkey brain (peak uptake = 0.37 Standard Uptake Values (SUV)).Despite our initial encouraging liver microsome and Caco-2 monolayer data, in addition to the observed high stability of [11C]AZD1283 in formulation and human serum, in vivo brain uptake was negligible and rapid accumulation was observed in the liver of both naïve wildtype and P2Y12R knockout mice. Liver signal appeared to be independent of both metabolism and P2Y12R expression due to the confirmation of intact tracer in this tissue for both wildtype and P2Y12R knockout mice. In Rhesus Macaque, negligible uptake of [11C]AZD1283 brain indicates a lack of potential for translation or its further investigation in vivo. P2Y12R is an extremely promising potential PET biomarker, and the data presented here suggests encouraging metabolic stability for this scaffold; however, the mechanism of liver uptake in mice should be elucidated prior to further analogue development." @default.
• W4280496857 created "2022-05-22" @default.
• W4280496857 creator A5000806528 @default.
• W4280496857 creator A5001799210 @default.
• W4280496857 creator A5004622987 @default.
• W4280496857 creator A5013319200 @default.
• W4280496857 creator A5017201701 @default.
• W4280496857 creator A5020804337 @default.
• W4280496857 creator A5021420538 @default.
• W4280496857 creator A5026737730 @default.
• W4280496857 creator A5031612620 @default.
• W4280496857 creator A5032425304 @default.
• W4280496857 creator A5034046462 @default.
• W4280496857 creator A5040592812 @default.
• W4280496857 creator A5043094673 @default.
• W4280496857 creator A5052515874 @default.
• W4280496857 creator A5052853323 @default.
• W4280496857 creator A5058261586 @default.
• W4280496857 creator A5087461202 @default.
• W4280496857 date "2022-11-01" @default.
• W4280496857 modified "2023-10-16" @default.
• W4280496857 title "Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer" @default.
• W4280496857 cites W1996024251 @default.
• W4280496857 cites W2003674452 @default.
• W4280496857 cites W2016575780 @default.
• W4280496857 cites W2045347306 @default.
• W4280496857 cites W2058593769 @default.
• W4280496857 cites W2067499927 @default.
• W4280496857 cites W2086367742 @default.
• W4280496857 cites W2124836944 @default.
• W4280496857 cites W2131686384 @default.
• W4280496857 cites W2132513445 @default.
• W4280496857 cites W2175932639 @default.
• W4280496857 cites W2312272959 @default.
• W4280496857 cites W2531941507 @default.
• W4280496857 cites W2554948325 @default.
• W4280496857 cites W2620266814 @default.
• W4280496857 cites W2776178399 @default.
• W4280496857 cites W2898999667 @default.
• W4280496857 cites W2914051519 @default.
• W4280496857 cites W2998819749 @default.
• W4280496857 cites W3005154746 @default.
• W4280496857 cites W3039259383 @default.
• W4280496857 cites W3212303128 @default.
• W4280496857 doi "https://doi.org/10.1016/j.nucmedbio.2022.05.001" @default.
• W4280496857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35680502" @default.
• W4280496857 hasPublicationYear "2022" @default.
• W4280496857 type Work @default.
• W4280496857 citedByCount "2" @default.
• W4280496857 countsByYear W42804968572023 @default.
• W4280496857 crossrefType "journal-article" @default.
• W4280496857 hasAuthorship W4280496857A5000806528 @default.
• W4280496857 hasAuthorship W4280496857A5001799210 @default.
• W4280496857 hasAuthorship W4280496857A5004622987 @default.
• W4280496857 hasAuthorship W4280496857A5013319200 @default.
• W4280496857 hasAuthorship W4280496857A5017201701 @default.
• W4280496857 hasAuthorship W4280496857A5020804337 @default.
• W4280496857 hasAuthorship W4280496857A5021420538 @default.
• W4280496857 hasAuthorship W4280496857A5026737730 @default.
• W4280496857 hasAuthorship W4280496857A5031612620 @default.
• W4280496857 hasAuthorship W4280496857A5032425304 @default.
• W4280496857 hasAuthorship W4280496857A5034046462 @default.
• W4280496857 hasAuthorship W4280496857A5040592812 @default.
• W4280496857 hasAuthorship W4280496857A5043094673 @default.
• W4280496857 hasAuthorship W4280496857A5052515874 @default.
• W4280496857 hasAuthorship W4280496857A5052853323 @default.
• W4280496857 hasAuthorship W4280496857A5058261586 @default.
• W4280496857 hasAuthorship W4280496857A5087461202 @default.
• W4280496857 hasConcept C136339569 @default.
• W4280496857 hasConcept C150903083 @default.
• W4280496857 hasConcept C151730666 @default.
• W4280496857 hasConcept C185592680 @default.
• W4280496857 hasConcept C202751555 @default.
• W4280496857 hasConcept C203014093 @default.
• W4280496857 hasConcept C207001950 @default.
• W4280496857 hasConcept C2775842073 @default.
• W4280496857 hasConcept C2776914184 @default.
• W4280496857 hasConcept C2776970183 @default.
• W4280496857 hasConcept C2779343474 @default.
• W4280496857 hasConcept C2779830541 @default.
• W4280496857 hasConcept C29331040 @default.
• W4280496857 hasConcept C2989005 @default.
• W4280496857 hasConcept C55493867 @default.
• W4280496857 hasConcept C67847695 @default.
• W4280496857 hasConcept C71924100 @default.
• W4280496857 hasConcept C86803240 @default.
• W4280496857 hasConcept C87753298 @default.
• W4280496857 hasConcept C98274493 @default.
• W4280496857 hasConceptScore W4280496857C136339569 @default.
• W4280496857 hasConceptScore W4280496857C150903083 @default.
• W4280496857 hasConceptScore W4280496857C151730666 @default.
• W4280496857 hasConceptScore W4280496857C185592680 @default.
• W4280496857 hasConceptScore W4280496857C202751555 @default.
• W4280496857 hasConceptScore W4280496857C203014093 @default.
• W4280496857 hasConceptScore W4280496857C207001950 @default.
• W4280496857 hasConceptScore W4280496857C2775842073 @default.
• W4280496857 hasConceptScore W4280496857C2776914184 @default.
• W4280496857 hasConceptScore W4280496857C2776970183 @default.

• next